Climate Change Data

Marksans Pharma Limited

Climate Impact & Sustainability Data (2019-04 to 2020-03, 2020-21, 2021-22, 2022-23, 2023-24)

Reporting Period: 2019-04 to 2020-03

Environmental Metrics

ESG Focus Areas

  • Ethics, Transparency and Accountability
  • Safety and sustainability throughout the life cycle of goods and services
  • Well-being of all employees
  • Respect and promotion of human rights
  • Respect, protection, and restoration of the environment
  • Responsible influencing of public and regulatory policy
  • Inclusive growth and equitable development
  • Providing value to customers and consumers responsibly

Environmental Achievements

  • Company’s processes are more resource efficient, uses renewable energy sources and minimises release of wastes in the environment. Emissions/Wastes generated by the Company are within the permissible limits and during the year, the Company has not received any show cause or legal notice on environment issue. The Company’s plant is environment regulations compliant.

Social Achievements

  • 80 women employees out of a total of 790 permanent employees. No complaints related to child labor, forced labor, involuntary labor, or sexual harassment.
  • Safety and skill up-gradation training imparted to employees periodically.
  • CSR contributions to Ministry of Health, Government of Goa (women and child development, Anganwadis, national nutrition mission, fire department equipment), Cherish Life India Foundation (pediatric hematology oncology), and Sri Sathya Sai Mobile Medicare Project (free medicines).

Governance Achievements

  • Policies and procedures to ensure high levels of governance and ethics, transparency, and accountability in business transactions.
  • Whistleblower policy in place.
  • No complaints received on unethical practices or human rights violations during the year.

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2020-21

Environmental Metrics

Total Energy Consumption:64636372.00 (2020-21); 58303692.00 (2019-20)

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Efficient use of resources to minimize waste generation
  • Prioritise energy conservation measures including regular review of energy generation and consumption with effective control on utilization of energy
  • Committed to protect environment and ecological balance also maintaining quality of soil, air and water

Social Achievements

  • Our Human Resource (HR) strategy of “Our People, Our Organisation,” defines the aspirations of our workforce.
  • Our policies are curated to address every employee working at Marksans and nurture a conducive environment to attract and retain the finest talents from the industry.
  • We aim to ensure social and economic dignity and freedom regardless of nationality, gender, race, economic status or religion to all its talents at all level.
  • During these challenging times, we distributed free food items to the people affected by lockdowns, donated fans for Covid Centres, undertook antibody testing and other medical test for migrant workers, and provided essential supplies, medicines, sanitisers, masks, gloves and PPE kits to the frontline health workers.

Governance Achievements

  • At Marksans, we are driven by a strong governance framework that forms the foundation of our business.
  • Our detailed policies covering various aspects of operations and strategy, help us deliver on our long-term goals.
  • We ensure our operating model is in collaboration with the expectation of all our stakeholders.

Climate Goals & Targets

Environmental Challenges

  • Sustaining growth momentum in a challenging business ecosystem
  • Failure to meet regulatory or ethical requirements for drug development
  • Inability to keep pace with technological advances in the industry
  • Inability to attract and retain qualified personnel
  • Stiff competition from multiple pharma players across regions
Mitigation Strategies
  • Strong R&D capabilities to develop differentiated products
  • Quality management systems to monitor and assure that the products are in line with international standards
  • Regular technological advancement initiatives and investments to match changing trends
  • Periodic investments in employees and adequate rewards
  • Strong marketing and business development team to monitor market trends

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2021-22

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Minimising waste generation and prioritising energy saving methods
  • Improved water and energy management and reduced carbon footprint

Social Achievements

  • Employee centric approach helps build expertise, skill sets and integrity among our employees
  • Strong learning culture and dedicated training programs provide agility and resilience to our workforce
  • Support disadvantaged groups through our dedicated community development programs

Governance Achievements

  • Governance framework encompasses major legislative and regulatory compliances
  • Building a strong leadership team and Board of Directors

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Generating more than 10% of its overall revenue from emerging markets by 2025
Short-term Goals:
  • Achieving our Rs. 2,000 Crores milestone in the near future along with improved profitability

Environmental Challenges

  • Rising input costs and supply chain disruptions
  • Significant portion of raw materials are sourced from China, lockdowns in major industrial cities created further supply chain bottlenecks
  • Substantial increase in input costs such as freight, packaging and raw materials
Mitigation Strategies
  • Sustained financial performance is a result of our resilient business model
  • Improved product mix, reduced financial costs and lower tax outgo helped us to neutralize the cost pressures
  • Strategic long-term contracts enabled to limit the impact volatility of cost and supply chain on profitability and margins
  • Implementation of digital initiatives have also helped optimise costs and strengthen profitability

Supply Chain Management

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (UN SDGs)

Certifications: USFDA, UK MHRA and Australian TGA

UN Sustainable Development Goals

  • Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2022-23

Environmental Metrics

Total Energy Consumption:58560638 MJ
Water Consumption:89775 KL
Waste Generated:23.594 metric tonnes

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • 6% Y-o-Y reduction in water consumption
  • Implementation of energy conservation measures resulting in considerable savings

Social Achievements

  • Contribution to social and economic development, striving to build a better, more sustainable way of life for the weaker sections of society
  • Provided medical treatment to individuals suffering from cancer and other blood disorders within the underprivileged society
  • Contributed to the construction of a building dedicated to providing nursing education to economically challenged students from rural areas across Goa
  • Supported the fight against the COVID-19 pandemic by allocating resources to cover testing and other medical charges for local communities and distributing essential supplies

Governance Achievements

  • High level of governance and ethics, transparency and accountability in business transactions
  • Implementation of a whistle blower policy

Climate Goals & Targets

Long-term Goals:
  • OTC growth to remain a focus area
Medium-term Goals:
  • Rank amongst Top 10 Indian Pharma companies in US and Top 3 Indian Pharma Companies in the UK
  • Add new 10-12 new products in UK and USA every year
  • Generate 10% of the revenue from Rest of World (ROW)
Short-term Goals:
  • Reach Rs 2,000 crores in revenues
  • Improve margins over the next couple of years
  • Deliver superior returns for shareholders
  • File 34 new products in the UK over the next three years

Environmental Challenges

  • High inflation
  • Input cost pressures
  • Supply chain disruptions
  • Price erosion in end-user market
  • Volatility in raw material and freight costs
  • Intense competition from pharma companies
Mitigation Strategies
  • Proactive cost optimization measures
  • Focus on new product launches
  • Uncompromising quality
  • Robust financial control mechanism
  • Long-term contracts with suppliers
  • Enhanced working capital cycle
  • Reliable network of suppliers
  • State-of-the-art manufacturing and strong R&D capabilities

Supply Chain Management

Responsible Procurement
  • Raw Materials/formulations are sourced from suppliers approved by regulatory authorities

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (UN SDGs)

Certifications: US-FDA, MHRA, Australian Government (Department of Health), TGA

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:23130.25 tCO2e
Scope 1 Emissions:23130.25 tCO2e
Scope 2 Emissions:0 tCO2e
Scope 3 Emissions:0 tCO2e
Renewable Energy Share:0%
Total Energy Consumption:82308912.12 MJ
Water Consumption:78387.66 KL
Waste Generated:28.755 tons
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental Sustainability
  • Social Responsibility
  • Governance

Environmental Achievements

  • Minimized environmental footprint through energy-efficient technologies and waste reduction initiatives
  • Implemented effective measures to reduce water consumption
  • Recycled 15.199 metric tons of waste

Social Achievements

  • Contributed to the socioeconomic growth of society, aiming for a more equitable and sustainable way of life for marginalized people
  • Undertook several initiatives in collaboration with local communities and organizations to address social challenges and promote inclusive development
  • Zero complaints on discrimination or sexual harassment

Governance Achievements

  • Upholding the principles of good corporate governance to achieve long-term goals and increase shareholder value
  • Strong internal control system, processes and codes of conduct
  • Diverse Board of Directors

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Increased expenditure due to the Red Sea crisis leading to supply chain disruptions
  • Moderate pricing pressure on Rx products in the US
Mitigation Strategies
  • Strategized routes and optimized delivery time to address supply chain disruptions
  • Increased inventory levels of finished products and key raw materials in US warehouses
  • Strategic pricing and cost-control measures to manage pricing pressure

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Raw Materials/formulations are sourced from suppliers approved by regulatory authorities

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: USFDA, UK MHRA, Australian TGA, EU, Health Canada and Japanese Health Authority

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed